TABLE 2.

Cumulative incidence of cause-specific death and Gray’s test in the whole set.

Characteristics	CVD (%)			P	Non-CVD (%)			P
	1-year	3-year	5-year		1-year	3-year	5-year
Total	12.20	24.25	30.51		1.93	4.13	4.77
Year of diagnosis				<0.001				0.01
2007–2010	1.84	3.47	4.99		2.10	4.30	6.60
2011–2015	1.46	2.89	4.49		1.79	3.99	6.45
Age				<0.001				<0.001
<65	0.44	0.94	1.39		0.87	1.95	2.99
≥65	2.82	5.34	7.89		2.97	6.26	9.79
Sex				0.210				0.010
Female	1.55	3.03	4.65		1.83	3.95	6.27
Male	1.71	3.28	4.77		2.01	4.31	6.67
Race				<0.001				<0.001
Black	1.72	3.23	4.46		1.99	4.27	6.35
White	1.68	3.26	4.91		2.00	4.26	6.70
Others	1.14	2.19	3.20		1.20	2.87	4.65
Marital status				<0.001				<0.001
Married	1.23	2.40	3.63		1.46	3.26	5.31
Unmarried	2.15	4.15	6.13		2.53	5.26	8.00
Insurance status				<0.001				<0.001
Any Medicaid	1.89	3.65	5.16		2.63	5.33	7.66
Insured	0.70	1.43	2.14		1.29	2.78	3.62
Uninsured	1.63	3.16	4.75		1.85	4.01	6.42
Tumor site				<0.001				<0.001
Left	1.34	2.65	3.89		1.55	3.40	5.32
Right	1.94	3.69	5.59		2.30	4.90	7.71
NOS	2.07	3.82	4.97		3.20	5.05	6.79
Tumor size				<0.001				<0.001
≤5 cm	1.53	3.14	4.84		1.77	4.16	6.73
5–10 cm	1.79	3.30	4.78		2.07	4.19	6.40
>10 cm	1.72	3.02	4.18		2.22	3.97	5.76
Grade				<0.001				<0.001
Grade I	1.22	2.86	4.58		1.64	3.90	6.46
Grade II	1.64	3.20	4.83		1.86	4.17	6.59
Grade III	1.86	3.18	4.34		2.25	4.08	6.06
Grade IV	1.79	3.29	4.50		2.61	4.51	6.19
SEER stage				<0.001				<0.001
Localized	1.71	3.72	5.93		1.99	4.81	8.08
Regional	1.72	3.22	4.75		1.98	4.20	6.52
Distant	1.29	1.91	2.17		1.69	2.63	3.15
Surgery				<0.001				<0.001
No	2.48	3.55	4.13		3.05	4.55	5.40
Yes	1.55	3.12	4.77		1.81	4.09	6.59
Radiotherapy				<0.001				<0.001
No	1.78	3.42	5.08		2.09	4.42	6.90
Yes	0.77	1.66	2.53		0.97	2.47	4.00
Chemotherapy				<0.001				<0.001
No	2.36	4.47	6.62		2.74	5.60	8.74
Yes	0.61	1.33	2.02		0.78	2.07	3.29

Other, American Indian/Alaska Native/Asian/Pacific Islander; NOS, not otherwise specified; SEER, Surveillance, Epidemiology, and End Results.